2023年上海生物医药产业发展报告  

Shanghai report on the development of biopharmaceutical industry in 2023

作　　者：巢艾伦 杨依晗 李明 李玉珊 黄堃 王广平 胡骏 CHAO Aiun;YANG Yihan;LI Ming;LI Yushan;HUANG Kun;WANG Guangping;HU Jun(Shanghai Center for Adverse Drug and Medical Device Reaction Monitoring,Shanghai 200040,China;Shanghai Biopharmaceutical Industry Association,Shanghai 201203,China;School of Medicine,Shanghai University,Shanghai 200444,China)

机构地区：[1]上海市药品和医疗器械不良反应监测中心,上海200040 [2]上海市生物医药行业协会,上海201203 [3]上海大学医学院,上海200444

出　　处：《上海医药》2025年第1期3-7,共5页Shanghai Medical & Pharmaceutical Journal

摘　　要：生物医药产业是上海市战略性新兴产业的重要支柱。受国内外复杂环境影响,2023年上海生物医药产业发展增速放缓。本文分析上海生物医药产业发展现状,并就加速上海生物医药产业发展提出相关建议。Biopharmaceutical industry is an important pillar of strategic emerging industries in Shanghai.The growth rate of Shanghai’s biopharmaceutical industry has been slowed down in 2023 due to affection by the complex environment at home and abroad.This article focuses on the analysis of the status quo of Shanghai’s biopharmaceutical industry and makes recommendations for accelerating the development of this industry.

关 键 词：生物医药产业 药品 医疗器械 创新发展 

分 类 号：F426[经济管理—产业经济] R95[医药卫生—药学]